KRYS
Krystal Biotech, Inc. (KRYS) Investor Questions
Review Krystal Biotech, Inc. (KRYS) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Krystal Biotech, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 86
- Annual revenue
- $389.13M
- Annual net income
- $204.83M
- Annual free cash flow
- $188.91M
Krystal Biotech, Inc. (KRYS) Investor Questions research
Krystal Biotech, Inc. trades under the ticker KRYS. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review KRYS through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.